Skip to main content
Clinical Trials/NCT02574702
NCT02574702CompletedNot Applicable

Prospective Randomized Controlled Trial to Reduce the Superficial Surgical Site Infection Due to a Contralateral Drainage Application in Loop Ileostomy Closure

Corporacion Parc Tauli2 sites in 1 country78 target enrollmentStarted: February 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
78
Locations
2
Primary Endpoint
Number of patients with surgical site infection after ileostomy closure depending if there is or not a penrose drainage application

Study Overview

Brief Summary

  1. Introduction:

The most common complication of loop ileostomies closure for rectal cancer patients undergoing a low anterior rectum resection, is the superficial surgical site infection (incidence 2-40%). There are various techniques related to closing loop ileostomy. In a retrospective study at our center, the investigators objectify that superficial surgical site infection rate was reduced by more than a half by the application of a contralateral drainage (Penrose ®) in primary loop ileostomy closure. 2. Objectives and Hypothesis:

Hypothesis: The application of a contralateral drainage (Penrose ®) in primary loop ileostomy closure (in carriers of loop ileostomy by a low anterior rectum resection for rectal cancer) reduces the superficial surgical site infection.

Main objective: To reduce the rate of superficial surgical site infection by the application of a contralateral drainage (Penrose ®) in surgical wound of primary loop ileostomy closure. 3. Methodology:

Prospective and randomized clinical trial on the effectiveness of contralateral Penrose® drainage implementation in those patients that have a primary loop ileostomy (by low anterior rectum resection) closure to be able to know if the investigators can reduce the superficial surgical site infection rate. Monitorization until 30 days after surgery

Detailed Description

  1. Introduction:

The most common complication of loop ileostomies closure for rectal cancer patients undergoing a low anterior rectum resection, is the superficial surgical site infection (incidence 2-40%). In the literature there are various techniques related to closing loop ileostomy that try to reduce the rate of infections recorded. In a retrospective study at our center, the investigators objectify that superficial surgical site infection rate was reduced by more than a half by the application of a contralateral drainage (Penrose ®) in primary loop ileostomy closure. 2. Objectives and Hypothesis:

Hypothesis: The application of a contralateral drainage (Penrose ®) in primary loop ileostomy closure (in carriers of loop ileostomy by a low anterior rectum resection for rectal cancer) reduces the superficial surgical site infection.

Main objective: To reduce the rate of superficial surgical site infection by the application of a contralateral drainage (Penrose ®) in surgical wound of primary loop ileostomy closure.

Secondary objectives:

  • Identify risk factors associated with superficial surgical site infection in relation to a primary loop ileostomy closure (with or without drainage).
  • Reducing hospital stay and care at home.
  1. Methodology:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Any patient carrying loop ileostomy due to low anterior resection for rectal cancer.
  • Over 18 years.
  • Surgery scheduled.
  • Informed consent signed.

Exclusion Criteria

  • Patients with terminal ileostomy.
  • Patients with loop ileostomy different from any surgery of rectal cancer.
  • To require another surgical procedure added.
  • Urgent surgery.
  • Patient refusal to participate in the study.

Arms & Interventions

Control Group

No Intervention

Patients with primary loop ileostomy closure without drainage of the surgical wound

Drainage Group

Experimental

Patients with the application of a contralateral drainage (Penrose ®) in surgical wound of primary loop ileostomy closure.

Intervention: application of a contralateral drainage in surgical wound closure.

Intervention: application of a contralateral drainage (Penrose ® device) (Procedure)

Outcomes

Primary Outcomes

Number of patients with surgical site infection after ileostomy closure depending if there is or not a penrose drainage application

Time Frame: 30 days

Secondary Outcomes

  • Number of patients with seroma after ileostomy closure surgery(30 days)
  • Number of patients with anastomotic leak after ileostomy colsure surgery(30 days)
  • Number of patients with hematoma after ileostomy closure surgery(30 days)

Investigators

Sponsor
Corporacion Parc Tauli
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xavier Serra-Aracil

Medical Doctor

Corporacion Parc Tauli

Study Sites (2)

Loading locations...

Similar Trials